One of the world's leading producers of diagnostic tests has been falsely marketing one of their products, an investigation by the BMJ shows. Oxoid, owned by US diagnostics giant Thermofisher, has been selling antimicrobial susceptibility test (AST) discs that do not always contain the advertised amount of antibiotic. The $10 billion a year company's website claims that it is "renowned for quality, accuracy, reliability and innovation." However, internal documents seen by the BMJ show that this reputation may not be entirely justified...
More...
More...